SCHEMBL29353487

SCHEMBL29353487

O=[N+]([O-])c1cc(Cl)ccc1N=Nc1c(O)ccc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 4/20 0.51
▸ MAPT P10636 9/20 0.49
▸ L3MBTL1 Q9Y468 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ MAPK1 P28482 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ CYP1A2 P05177 2/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ TSHR P16473 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ PTPRA P18433 1/20 0.48
▸ PTPRB P23467 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ RAPGEF4 Q8WZA2 1/20 0.48
▸ KMT2A Q03164 7/20 0.46
▸ MEN1 O00255 6/20 0.46
▸ LMNA P02545 3/20 0.46
▸ HTT P42858 2/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5356875 1.00 THRB (0.51) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL5356868 1.00 THRB (0.51) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL305524 0.87 TSHR (0.57) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL305525 0.87 TSHR (0.57) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL29355385 0.87 TSHR (0.57) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL10809260 0.86 THRB (0.51) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL29353897 0.86 THRB (0.67) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL4223162 0.86 THRB (0.67) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL57955 0.86 THRB (0.67) THRBMAPTL3MBTL1NPC1MAPK1
SCHEMBL1394498 0.86 THRB (0.67) THRBMAPTL3MBTL1NPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110799346-B Ink jet recording method 花王株式会社 2022-02-01 — — CN claimed
US-12625441-B2 Electrostatic charge image developing toner and image forming method Konica Minolta, Inc. (JP) 2026-05-12 — — US disclosed
US-12606717-B2 Azo pigment, ink, paint, colorant for plastics, colored molded article, colorant for stationery and writing materials, printing agent, toner, dispersion and resist for color filters, and cosmetic material DIC CORPORATION (JP) 2026-04-21 — — US disclosed
US-12585208-B2 Glittering toner, toner-storing unit, developer, developer-storing unit,image forming apparatus, and image forming method RICOH COMPANY, LTD. (JP) 2026-03-24 — — US disclosed
EP-4328248-B1 ULTRAVIOLET-CURABLE WATER-BASED INK, DISPERSION, ULTRAVIOLET-CURABLE WATER-BASED COMPOSITION AND PRINTED MATTER MITSUBISHI CHEM CORP (JP) 2026-03-18 — — EP disclosed
EP-4703438-A1 ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER Mitsubishi Chemical Corporation (JP) 2026-03-04 — — EP disclosed
EP-4703514-A1 INK SET FOR INKJET TEXTILE PRINTING, INKJET TEXTILE PRINTING METHOD, AND INKJET TEXTILE PRINTING DEVICE Kyocera Corporation (JP) 2026-03-04 — — EP disclosed
EP-4703437-A1 ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER Mitsubishi Chemical Corporation (JP) 2026-03-04 — — EP disclosed
US-20260049225-A1 ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER MITSUBISHI CHEMICAL CORPORATION (JP) 2026-02-19 — — US disclosed
US-20260049224-A1 ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER MITSUBISHI CHEMICAL CORPORATION (JP) 2026-02-19 — — US disclosed
CN-110325601-B Liquid composition for inkjet and inkjet recording method 富士胶片株式会社 2022-03-15 — — CN disclosed
US-20220073769-A1 INKJET INK FOR TEXTILE PRINTING HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-03-10 — — US disclosed
US-20220073770-A1 NON-AQUEOUS INKJET INKS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-03-10 — — US disclosed
US-20220073773-A1 FLUID SET HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2022-03-10 — — US disclosed
US-11247502-B2 Inkjet image formation method Konica Minolta, Inc. (JP) 2022-02-15 — — US disclosed
US-11248136-B2 Ink jet liquid composition and ink jet recording method FUJIFILM CORPORATION (JP) 2022-02-15 — — US disclosed
CN-107922771-B Ultraviolet (UV) curable inkjet ink compositions 惠普发展公司,有限责任合伙企业 2022-02-11 — — CN disclosed
US-20220040980-A1 METHOD FOR CLEANING INK DISCHARGER OF INKJET HEAD Konica Minolta, Inc. (JP) 2022-02-10 — — US disclosed
CN-110799346-B Ink jet recording method 花王株式会社 2022-02-01 — — CN disclosed
EP-3762238-B1 INKJET PRE-TREATMENT FLUID FOR TEXTILE PRINTING HEWLETT PACKARD DEVELOPMENT CO (US) 2022-01-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12585208-B2 Glittering toner, toner-storing unit, developer, developer-storing unit,image forming apparatus, and image forming method SP1, PAX2, SNAP23 THRB 2524/4885MAPT 1066/4885L3MBTL1 2578/4885
US-12625441-B2 Electrostatic charge image developing toner and image forming method EWSR1, AFF4, DYRK2 THRB 3812/4885MAPT 222/4885L3MBTL1 2457/4885
US-20260049224-A1 ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER AURKA, CEP170, UFM1 THRB 3501/4885MAPT 16/4885L3MBTL1 604/4885
US-20260049225-A1 ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER CCND1, RIF1, CDH1 THRB 3286/4885MAPT 76/4885L3MBTL1 920/4885
US-12606717-B2 Azo pigment, ink, paint, colorant for plastics, colored molded article, colorant for stationery and writing materials, printing agent, toner, dispersion and resist for color filters, and cosmetic material TYR, MITF, IK THRB 3686/4885MAPT 793/4885L3MBTL1 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback